Palisade Bio PALI
NASDAQ PALI
$1.16 +0.03 (+3.10%)
As of: Nov 11, 2026 · 3:55 PM EST

Palisade Bio (PALI) Price to Sales (2012 - 2026)

Updated

Palisade Bio's (PALI) Price to Sales stood at 725.63 in Q2 2026.

Analysis

Palisade Bio (PALI) Price to Sales (2012 - 2026) Analysis & Trends

For FY2023, Palisade Bio's Price to Sales came in at 16.14.

  • Across earlier years, Price to Sales came in at 45139.90 in FY2020 (+538.8%) and 7066.53 in FY2019 (+682.0%).
  • The Q2 2026 figure is the highest quarterly Price to Sales since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Palisade Bio 239.59 Mn -265.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 572.48
Jun 30, 2026 725.63
Dec 31, 2023 16.14
Sep 30, 2023 17.04
Jun 30, 2023 46.58
Mar 31, 2023 60.77
Sep 30, 2022 97,424.55
Jun 30, 2022 89,713.19
Mar 31, 2022 128,856.36
Dec 31, 2020 45,139.90
Sep 30, 2020 37,101.38
Jun 30, 2020 33,667.00
Mar 31, 2020 16,450.57
Dec 31, 2019 7,066.53
Sep 30, 2019 15,288.25
Jun 30, 2019 18,724.72
Mar 31, 2019 1,540.59
Dec 31, 2018 903.64
Sep 30, 2018 1,595.18
Jun 30, 2018 1,649.92
API Access

Palisade Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=PALI&period=max&api_key=YOUR_API_KEY